Nuvation Bio News

Nuvation Bio | DEFR14A: Definitive proxy statement in connection with contested solicitations

Aug 13 16:11 ET

Nuvation Bio | S-3: Registration statement for specified transactions by certain issuers

Aug 5 17:02 ET

Nuvation Bio | 8-K: Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 5 08:42 ET

Nuvation Bio | DEF 14A: Definitive information statements

Jul 30 16:06 ET

Nuvation Bio | 8-K/A: Current report (Amendment)

Jun 20 17:28 ET

Nuvation Bio | PRE 14A: Preliminary proxy statements relating to merger or acquisition

May 24 16:43 ET

Nuvation Bio | 8-K: Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update

May 14 16:28 ET

Nuvation Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 18 16:58 ET

Nuvation Bio | 8-K: Current report

Apr 10 16:09 ET

Nuvation Bio | 8-K: Current report

Mar 25 07:08 ET

Nuvation Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 4 17:45 ET

Nuvation Bio | 8-K: Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Feb 29 16:55 ET

Nuvation Bio | 8-K: Current report

Jan 8 00:00 ET

Nuvation Bio | 8-K: Current report

Dec 14, 2023 16:02 ET

Nuvation Bio | 8-K: Current report

Nov 27, 2023 16:01 ET

Nuvation Bio | 8-K: Current report

Nov 13, 2023 16:11 ET

Nuvation Bio | 8-K: Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 2, 2023 16:23 ET

Nuvation Bio | 8-K: Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update

Aug 3, 2023 16:17 ET

Nuvation Bio | 8-K: Current report

May 16, 2023 16:03 ET

Nuvation Bio | 8-K: Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

May 4, 2023 16:16 ET